Join Now

GPX® Embolic Device meets Primary Endpoints in IDE Pivotal Trial

By Natalie Themm | Published July 14, 2026

Trial Reports 99% Successful Occlusion of Flow with 40 Investigators Delivering the New Embolic Through 20 Different Catheters.

Posted in BioUtah News | Tagged | Comments Off on GPX® Embolic Device meets Primary Endpoints in IDE Pivotal Trial

A Special Thanks To Our Legacy and Platinum Elite Members